Skip to main content
OpenTrials

Clinical trial condition

Cervical Cancer

Explore clinical trials studying Cervical Cancer. Study availability and eligibility vary by location and protocol.

898 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Cervical Cancer trial results

Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

NCT06459180

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) Mobile, Alabama, United States
  • Providence Alaska Medical Center ( Site 4137) Anchorage, Alaska, United States
  • HonorHealth (HH) ( Site 8002) Phoenix, Arizona, United States
  • Arizona Oncology Associates - HOPE ( Site 8001) Tucson, Arizona, United States
View all 240 locations
View Trial Details
Active, Not Recruiting

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

NCT06182241

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Cancer, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston University Boston, Massachusetts, United States
  • MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand Durban, KwaZulu-Natal, South Africa
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, United Kingdom
  • The Royal Marden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Breast Unit Sutton, United Kingdom
View Trial Details
Active, Not Recruiting

TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation

NCT03833479

Conditions
Advanced Cancer, Cervical Cancer, Female Urogenital Diseases, +12 more
Locations
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital Universitario Donostia- Donostia Unibertsitate Ospitalea Donostia / San Sebastian, Gipuzkoa, Spain
  • ICO Girona Girona, Spain
  • Hospital Universitario La Paz Madrid, Spain
View all 29 locations
View Trial Details

Related conditions